In atrial fibrillation, exercise capacity is often reduced. This is usually ascribed to a decreased cardiac output as compared with sinus rhythm. Very few studies, however, have focused on changes in the peripheral blood flow during atrial fibrillation as a potential mechanism for exercise limitation. The aim of the present study was to determine the effect of conversion of atrial fibrillation to sinus rhythm on peripheral blood flow.
Calf blood flow, using an electrocardiogram-triggered venous occlusion plethysmogTaph, and peak oxygen consumption (peak VOJ, using treadmill exercise testing, were studied in 28 patients with chronic atrial fibrillation eligible for electrical cardioversion. Measurements were performed before cardioversion, and repeated 1 day and 1 month thereafter. Calf blood flow at rest, maximal calf blood flow, and minimal calf vascular resistance during the hyperaemic response immediately following 700 J of calf exercise were determined plethysmographically.
One day and 1 month after cardioversion, 23 and 14 patients were still in sinus rhythm, respectively. In patients who still had sinus rhythm after 1 month, maximal calf blood flow increased from 33-7 ±12 to 400 ± 13 ml. 100 ml" 1 mJ "" 1 (P<001) and minimal calf vascular resistance fell from 3-2 ± 0-9 to 2-7 ± 0-7mmHg.ml"' . 100 ml" ' . min " ' (P<00\); peak VO 2 increased from 21-3 ±4 to 24-2 ± 5 ml. min" ' . kg" ' (/ > <0001). Calf blood flow at rest did not improve. In contrast, no significant changes in maximal calf blood flow, minimal calf vascular resistance and peak VO 2 occurred in patients who had atrial fibrillation I month after cardioversion. A significant correlation was found between changes in maximal calf blood flow and peak VO 2 1 month after cardioversion (r=O-53, P<00\). One day after cardioversion, no changes in calf blood flow or peak VO 2 were found, either in patients with sinus rhythm or atrial fibrillation.
In conclusion, transition from chronic atrial fibrillation to sinus rhythm is associated with a (delayed) improvement in maximal calf blood flow, minimal calf vascular resistance, and peak VO 2 .
Introduction
One of the main clinical characteristics of cardiac disease is an impaired exercise capacity. This may be due to a lack in capacity to adapt peripheral (muscle) blood flow to the increased demands during exercise. Usually this is ascribed to an insufficient increase in cardiac output. On the other hand the maximum peripheral blood flow is dependent on the vasodilatory reserve capacity and on cardiac output. Chronic reductions in cardiac reserve are associated with a fall in this vasodilatory reserve 1 '^1, probably due to functional or structural vessel wall changes' 5 " 81 . Atrial fibrillation is such an example of cardiac disease in which a reduction in exercise capacity is usually considered as a direct consequence of impaired cardiac output reserve 19 "" 1 . Very few studies, however, have focused on changes in the peripheral blood flow as a mechanism to explain impairment of functional status in atrial fibrillation.
The aim of the present study was to determine the role of peripheral vasodilatory reserve capacity as a potential mechanism for exercise limitation in patients with chronic atrial fibrillation. We therefore studied peak oxygen consumption (peak VOJ and peripheral (calf) blood flow at rest and its reserve after exercise (using venous occlusion plethysmography) in patients ACE=angiotensin converting enzyme; F = female; LA = left atrial size; LVEDD=left ventricular end-diastolic diameter; LVESD = left ventricular endsystolic diameter; M = male; NYHA = New York Heart Association.
with chronic atrial fibrillation before electrical cardioversion, and 1 day and 1 month thereafter. We also compared patients with sustained sinus rhythm to those in whom atrial fibrillation recurred or cardioversion failed.
Methods

Patients
Patients with chronic atrial fibrillation of more than 6 months duration accepted to undergo electrical cardioversion were eligible for the study. Exclusion criteria were: (a) paroxysmal atrial fibrillation; (b) myocardial infarction less than 6 months ago; (c) thyroid dysfunction; (d) use of beta-adrenergic blocking agents; and (e) anginal pain, chronic obstructive pulmonary disease, claudication or any other abnormality interfering with the performance of a treadmill exercise test or venous occlusion plethysmography. The study was approved by the institutional committee on human research and informed consent for participation in the study was obtained from all patients. The investigation conforms with the principles outlined in the Declaration of Helsinki. Twenty-eight patients were enrolled in the study. Baseline characteristics of these patients are depicted in Table 1 . Eleven patients did not have any underlying cardiac abnormality. All patients were in functional class I or II according to the New York Heart Association classification.
Study design
One day before cardioversion, patients underwent venous occlusion plethysmography to assess peripheral vasodilatory reserve capacity and treadmill exercise testing with gas exchange analysis to determine peak VO 2 . These measurements were repeated 1 day and 1 month after cardioversion. All patients were instituted on anticoagulant therapy, dose adjusted to create an International Normalized Ratio (INR) of 20-4-8, at least 4 weeks before cardioversion. Atrioventricular nodal blocking drugs (digitalis, verapamil, or both) were titrated to attain a resting heart rate <; 100 beats . min ~ ' before cardioversion. During the study, none of the patients were on class I or III antiarrhythmic drugs. Drug treatment, including digoxin and verapamil, was kept unchanged for the duration of the study. A standard two-dimensional echocardiogram was performed in all patients before cardioversion to assess left ventricular function and left atrial size.
Calf blood flow
Resting and maximal calf blood flow were measured non-invasively by plethysmography, using an electrocardiogram-triggered venous occlusion strain gauge plethysmograph with a pneumatically powered cuff inflator allowing rapid flow measurements
. This method is widely applied for assessment of peripheral blood flow. A close relation exists between blood flow measured by venous occlusion plethysmography and that measured by Doppler flow 1 ' 41 . Patients lay down on a bench in a room with a constant temperature of 22 °C. The legs were placed 15 cm above heart level and a single strand mercury-in-rubber strain gauge was placed around the widest part of each calf. The occlusion cuffs were placed just above the right and left knee. During plethysmographic measurements the circulation to the foot was not arrested. This was not considered necessary, since the primary aim of the study was to determine changes in vasodilator capacity and thus maximal flow. In our model the increase in calf blood flow during and after exercise depends almost exclusively on the increase in calf muscle blood flow. Venous occlusion was achieved by inflation of the cuffs up to 50 mmHg. Ten calf flow measurements were made in subjects at rest, by alternate occlusion and deflation of the cuffs during intervals of five to six heart beats.
Exercise hyperaemia
Measurements of the flow during exercise cannot be performed simply with venous occlusion plethysmography because the muscles move strongly and the volume changes during the contractions. Measurement of postexercise hyperaemia, on the other hand, is technically simple. Therefore, in the present study maximal calf blood flow was determined during the hyperaemic response following 700 J of calf exercise on a custom built calf-ergometer 1 ' 51 . Flow data were then obtained immediately after patients had terminated calf exercise. For this purpose, the occlusion cuffs around both calves were alternately inflated and deflated at intervals of four heart beats during a period of 5 min. Calf blood flow could be calculated from the rate of the initial increase in calf circumference during venous occlusion and was expressed as ml . 100 ml"' of calf tissue per minute. The average value of blood flow in the left and right calf was considered calf blood flow. The systemic blood pressure was measured repeatedly using a mercury sphygmomanometer with a standard 12 cm cuff at the left upper arm. The mean arterial pressure (MAP) was derived from the systolic (SBP) and diastolic blood pressure (DBP): MAP=DBP + (SBP-DBP)/3. Minimal calf vascular resistance (CVR) was calculated from mean arterial pressure and maximal calf blood flow: CVR = MAP/CBF.
Cardiopulmonary exercise testing
Exercise testing with respiratory gas exchange measurements was performed while patients exercised on a treadmill according to a modified Naughton protocol.
'
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. Oxygen consumption, carbon dioxide production, and respiratory exchange ratios were measured continuously during exercise using an automated gasexchange measuring system (Sensormedics system 2900, SensorMedics Corp, Anaheim, CA). Values were recorded at 20 s intervals through an on-line computer assembly (IBM computer systems, IBM Corp, Austin, TX). Prior to each exercise test, the flow-meter was calibrated with a 3 litre syringe and the gas-analysers were calibrated with nitrogen and standard oxygen/ carbon dioxide mixture. Blood pressure was measured with a mercury sphygmomanometer. The electrocardiogram was monitored continuously with a computerassisted system (Marquette Electronics Inc., Milwaukee, WI). Twelve-lead electrocardiogram recordings were obtained at rest, at the end of each 2 min stage, and at peak exercise. Before entering the study, patients underwent at least one exercise test to familiarize them with this technique. Patients were encouraged to exercise until symptoms forced them to stop. All patients terminated the test because of dyspnoea or fatigue, and in all patients the gas exchange anaerobic threshold (the point at which carbon dioxide production increased disproportionately in relation to oxygen consumption) and a respiratory exchange ratio >10 were reached. Peak VO 2 was defined as oxygen consumption (ml. min ~' . kg"') at peak exercise calculated as the mean of the values measured during the last minute of exercise. Heart rate during atrial fibrillation was determined by measuring the average heart rate during a period of 15 s.
Definition of terms
Peripheral vasodilatory reserve capacity was defined as the difference between calf blood flow at rest and maximal calf blood flow. Chronic atrial fibrillation was defined as repeatedly documented arrhythmia, without intercurrent sinus rhythm on routine 12-lead electrocardiograms recorded at consecutive out-patient visits before cardioversion. To exclude patients with paroxysmal (stress-induced) adrenergic atrial fibrillation 24 h Holter monitoring (Marquette Laser Holter Systems, Milwaukee, WI) was performed at least once in all patients in the week before cardioversion.
Statistical analysis
Data are reported as mean ± SD. Median values were used in case of a non-uniform distribution of variables. For the comparison of continuous normally distributed variables analysis of variance was used. Frequencies were compared by the chi-square test for equality of proportions and for small numbers (<10) with Yates' correction. For correlations the Pearson correlation coefficient was calculated. / } <005 was considered significant.
Results
Cardioversion
Twenty-three out of the 28 patients (82%) could be cardioverted to sinus rhythm and still had sinus rhythm after 1 day. During the first month following cardioversion, nine out of these 23 patients suffered a relapse of atrial fibrillation (all occurring during the first week). Thus, 1 month after cardioversion, 14 out of 28 patients (50%) were in sinus rhythm; the remaining 14 patients had atrial fibrillation. There were no statistically significant differences in clinical characteristics between patients in sinus rhythm and atrial fibrillation 1 month after cardioversion (Table 2) .
Exercise CBF and peak VO 2 before and after cardioversion Tables 3 and 4 present plethysmographic data obtained during exercise hyperaemia, and treadmill exercise data before and 1 month after cardioversion of patients in sinus rhythm and those in atrial fibrillation after 1 month, respectively. At baseline, plethysmographic and exercise data were similar in patients who had sinus rhythm and those who had atrial fibrillation 1 month after cardioversion (Tables 3 and 4 , columns 'baseline'). In patients having sinus rhythm 1 month after cardioversion, maximal calf blood flow increased from 33-7 ± 12-1 to 40-0 ± 12-9 ml . 100 ml" ' . min" ' (P<001), and since mean arterial pressure remained constant, calculated minimal calf vascular resistance fell significantly, from 3-23 ±0-91 to 2-70 ± 0-70 mmHg . 100 ml" ' . min " ' (P<001) ( 1). Peripheral vasodilatory reserve capacity increased from 30-6 ±11-9 to 36-2 ± 13-3 ml. 100 ml" ' . min" ' (P<001). Also, peak VO 2 improved, from 21-3 ±4-4 to 24-2 ±4-6 ml. min" 1 .kg" 1 (7 > <0-001), and both resting and maximal heart rate decreased. Calf blood flow at rest did not change (Table 3 ). In contrast, no changes in maximal calf blood flow, minimal calf vascular resistance, peripheral vasodilatory reserve capacity or peak VO 2 occurred in patients who had atrial fibrillation 1 month after cardioversion (Table  4 , Fig. 1 ). In the overall group of 28 patients, a significant correlation was found between the change in peak VO 2 and the change in maximal calf blood flow 1 month after cardioversion compared to baseline (r=0-53, / ) <0-01). No significant correlation, either before or after cardioversion, was found between the (absolute) value of maximal calf blood flow and peak VO 2 .
One day after cardioversion no improvement in maximal calf blood flow, minimal calf vascular resistance or peak VO 2 occurred. This held both for patients who were in sinus rhythm and those in atrial fibrillation at that time (Fig. 1) .
Significant changes in 'lifestyle' (including participation in exercise programs), cardiac events, the general medical condition, or medication (both cardiac and noncardiac) did not occur in any of the patients during the 1 month follow-up period.
Discussion
The present study is, to our knowledge, the first to demonstrate an improvement of peripheral vasodilatory reserve capacity after cardioversion of atrial fibrillation. Compared to a control group of patients with persistent arterial fibrillation, an increase in exercise calf blood flow was found in patients maintaining sinus rhythm for 1 month. This was paralleled by a decrease in peripheral vascular resistance. In addition, improvement of peak VO 2 followed the same time course. Our findings suggest that impairment of peripheral vasodilatory reserve capacity may contribute to exercise limitation in patients with atrial fibrillation. In one previous study, an increase in cerebral blood flow has been reported after transition from atrial fibrillation to sinus rhythm' 171 . However, since cerebral blood flow has its own autoregulative mechanisms, extrapolation of these results to the peripheral circulation may not be justified.
Mechanisms of improvement in vasodilatory reserve capacity
Several mechanisms may be responsible for the increase in calf vasodilatory reserve capacity and peak VO 2 observed in the present study. First, although not the subject of our investigation, cardiac output may have increased in patients in whom sinus rhythm was restored. Several invasive haemodynamic studies have shown that cardiac output increases immediately (i.e. within 24 h) after restoration of sinus rhythm' 1 s~20 \ Others have demonstrated that improvement of cardiac output may occur over several weeks following cardioversion at least in part due to delayed restoration of atrial mechanical activity 24-2| 4-6 BL = baseline; CBF^^calf blood flow at rest; CBF IIUL , = maximal calf flow; CVR min = minimal calf vascular resistance; HR n cardioversion; MAP = mean arterial blood pressure; VO 2 = oxygen consumption, vs baseline; f/ > <002 vs baseline; J/ J <0-0OI vs baseline. , = heart rate at rest; HR ma , = maximal heart rate; 1 M = I month after 94  91  110  97  114  106  117  87  100  117  98   103  9   105  98  103  78  97  116  90  120  98  112  88  104  116  94   101  11   88  74  94  78  97  96  84  99  93  92  72  96  97  79   89  9   76  74  90  80  99  91  91  96  87  84  71  83  90  63   84  10   189  182  127  152  171  189  166  188  188  180  178  169  189  142   172  19   167  182  129  172  153  200  172  168  186  201  168  156  193  136   170  21 16 I ra BL = baseline; CBF ral =calf blood flow at rest; CBF lrm]1 = maximal calf flow; CVR mln = minimal calf vascular resistance; HR rcs , = heart rate at rest; HR n "• cardioversion; MAP=mean arterial blood pressure; VO 2 = oxygen consumption. However, it must be noted that the localized hyperaemic response after selective (calf) exercise is relatively independent of the actual cardiac output. In patients with congestive heart failure, it has been demonstrated that the vasodilatory response to exercise is fixed and independent of global left ventricular performance (i.e. cardiac output)' 2 ' 31 . Furthermore, pharmacological studies also show a discrepancy between changes in cardiac output and peripheral blood flow in these patients: dobutamine infusion during exercise results in an increase in cardiac output, but not in blood flow 1221 . In another study by Levine et a/.' 231 captopril increased cardiac index but not forearm blood flow. Therefore, it is unlikely that a (delayed) increase in cardiac output may fully explain our observations. A second potential mechanism explaining our observations is that restoration of sinus rhythm may have led to increased physical activity in our patients, which in turn may have resulted in an increase in vasodilatory reserve capacity ('training effect') 124 '-There were, however, no differences in the number of patients participating in exercise or rehabilitation programmes between the patient group in sinus rhythm and that in atrial fibrillation 1 month after cardioversion. Nevertheless, from the present study we cannot exclude that a training effect may have played some role. Finally, primary adaptation in the peripheral vasculature after restoration of sinus rhythm may have contributed to the improvement in calf blood flow reserve and peak VO 2 . Obviously, this adaptation is triggered by the changed central haemodynamic situation. In patients with chronic heart failure it has been demonstrated that inotropic or vasodilator therapy improves cardiac output immediately without a corresponding increase in exercise capacity' . In addition, it was shown that improvement in exercise capacity was delayed and limited to patients in whom skeletal muscle blood flow increased' 28 '. In our patients, improvement 1 month after cardioversion was also restricted to patients whose calf vasodilatory reserve had improved, i.e. patients who had sinus rhythm at that time. The above mentioned suggests that slow adaptation plays an important role in the changes in peripheral blood flow after restoration of sinus rhythm' 29 '.
Although beyond the scope of this study, in addition to improvement in peripheral vasodilatory reserve capacity, changes in the skeletal muscle itself following successful cardioversion may also contribute to the improvement in exercise capacity. In patients with congestive heart failure, it has been demonstrated that indices of muscle performance are frequently impaired, even when heart failure is mild' 30 . From the present study, however, it cannot be concluded whether similar mechanisms are operative in patients with atrial fibrillation and mild, or even absent heart failure.
Study limitations
There are three limitation of the present study. First, measurement of blood flow using plethysmography has methodological limitations. Although plethysmographically-obtained blood flow correlates with true flow, it is still an estimate of true flow and may under-or overestimate flow in some patients' 351 . However, this limitation may be obviated by the fact that in the present study changes rather than absolute values of blood flow were of particular importance. Also, it is questionable whether measurements of blood flow and blood pressure are reliable in atrial fibrillation. Indeed beat-to-beat variations in blood flow and pressure will occur during atrial fibrillation. However, as each point in the calf blood flow curve is based on the angle of the plethysmographic curve over four heart cycles (inflation phase), this averaging effect will smooth the beat-to-beat variations and thereby limit their influence. The same holds for blood pressure values, which were also averaged over several beats. In this respect, ventricular response during atrial fibrillation may also be of importance. It is conceivable that 'inappropriate' rapid heart rates during blood flow measurements may be accompanied by a fall in cardiac output, thereby resulting in a decreased blood flow. However, since our patients were on AV nodal blocking drugs, ventricular response was well regulated and we feel that an excessive heart rate response is not very likely to have influenced our results significantly.
Second, the present study did not include measurement of cardiac output. Consequently, it cannot be excluded that the increase in maximal calf blood flow was due to an increase in cardiac output following restoration of sinus rhythm.
Third, we compared results of patients maintaining sinus rhythm after cardioversion with a control group of patients remaining in atrial fibrillation or having an arrhythmia relapse in the first month following cardioversion. Patients, however, were not randomized to cardioversion or pharmacological rate control only. This may have introduced a bias leading to selection of patients in the control group not improving their peripheral flow or peak VO 2 for other reasons than arrhythmia outcome. However, at baseline, patient groups were similar, and using established clinical parameters predicting relapse of atrial fibrillation there were also no differences between the groups.
Conclusion
Transition of atrial fibrillation to sinus rhythm is associated with a delayed improvement in peripheral vasodilatory reserve capacity and peak VO 2 . Further efforts to identify the precise mechanisms responsible for these findings are warranted since they may appear helpful in clarifying the clinical characteristics of atrial fibrillation patients and their response to cardioversion.
